Internal Medicine, Hematology & Oncology · Baltimore, MD
NPI
1619387867
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6535 N Charles St Ste 220
Baltimore, MD, 21204
Phone (443) 849-3051
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,160 services
Medicare patients, 2024
354
Average age 75
Drug cost, 2024
$3.1M
828 prescriptions
Company payments, 2025
$17K
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhuoyan Li was code 99214 (office e&m - established), 448 times for 216 patients. In total Zhuoyan Li billed 1,160 services in 12 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 448 | 216 | $91.74 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 333 | 154 | $13.20 | $4,397 |
| 99215 Office E&M - Established | Office | 158 | 84 | $137.20 | $22K |
| 99213 Office E&M - Established | Office | 90 | 72 | $66.77 | $6,009 |
| 99205 Office E&M - New | Office | 56 | 56 | $170.98 | $9,575 |
| 99204 Office E&M - New | Office | 32 | 32 | $123.27 | $3,945 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $137.58 | $2,339 |
By year: 2022 $66K for 640 services; 2023 $94K for 815 services; 2024 $91K for 1,160 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zhuoyan Li prescribed most often to Medicare patients was Anastrozole, with 139 prescriptions and refills. In total Zhuoyan Li wrote 828 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 139 | 388 | 53 | $3,160 |
| Letrozole Generic | 73 | 149 | 19 | $1,174 |
| Lenalidomide Generic | 54 | 54 | Under 11 | $765K |
| Eliquis Apixaban | 51 | 85 | 13 | $49K |
| Hydroxyurea Generic | 44 | 121 | 14 | $1,387 |
| Besremi Ropeginterferon Alfa-2b-Njft | 41 | 41 | Under 11 | $553K |
| Tamoxifen Citrate Generic | 38 | 102 | 15 | $1,204 |
| Acyclovir Generic | 35 | 84 | 12 | $899 |
| Xarelto Rivaroxaban | 30 | 58 | Under 11 | $32K |
| Prochlorperazine Maleate Generic | 29 | 29 | 21 | $318 |
| Revlimid Lenalidomide | 22 | 22 | Under 11 | $359K |
| Verzenio Abemaciclib | 21 | 21 | Under 11 | $315K |
| Dexamethasone Generic | 21 | 31 | 13 | $766 |
| Calquence Acalabrutinib Maleate | 20 | 20 | Under 11 | $268K |
| Jakafi Ruxolitinib Phosphate | 17 | 17 | Under 11 | $292K |
Brand drugs: 244 claims; generic drugs: 584 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhuoyan Li $17K ($17K in general payments such as food, travel and fees) from 38 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $11K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $11K |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $2,570 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $1,613 |
| Janssen Biotech, Inc. JNJ | 8 | $273 |
| Gilead Sciences, Inc. GILD | 4 | $254 |
| Celgene Corporation BMY | 5 | $241 |
| Abbvie Inc. ABBV | 5 | $135 |
| Merck Sharp & Dohme LLC MRK | 4 | $97.63 |
| Exelixis Inc. EXEL | 3 | $85.83 |
| Daiichi Sankyo Inc. 4568.T | 3 | $76.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.